Yayi Swain1,2, Peter Muelken1, Annika Skansberg1,2, Danielle Lanzdorf1,2, Zachary Haave1,3, Mark G LeSage1,2,4, Jonathan C Gewirtz2,3, Andrew C Harris5,6,7. 1. Hennepin Healthcare Research Institute, 701 Park Avenue, Minneapolis, MN, 55415, USA. 2. Department of Psychology, University of Minnesota, Minneapolis, MN, USA. 3. Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA. 4. Department of Medicine, University of Minnesota, Minneapolis, MN, USA. 5. Hennepin Healthcare Research Institute, 701 Park Avenue, Minneapolis, MN, 55415, USA. harr0547@umn.edu. 6. Department of Psychology, University of Minnesota, Minneapolis, MN, USA. harr0547@umn.edu. 7. Department of Medicine, University of Minnesota, Minneapolis, MN, USA. harr0547@umn.edu.
Abstract
RATIONALE: Understanding factors contributing to individual differences in vulnerability to opioid addiction is essential for developing more effective preventions and treatments, yet few reliable behavioral predictors of subsequent opioid self-administration have been identified in rodents. Sensitivity to the acute effects of initial drug exposure predicts later addiction vulnerability in both humans and animals, but the relationship between sensitivity to withdrawal from initial drug exposure and later drug use vulnerability is unclear. OBJECTIVE: The goal of the current study was to evaluate whether the degree of anhedonia experienced during withdrawal from early opioid exposure predicts subsequent vulnerability to opioid self-administration. METHODS: Rats were first tested for withdrawal sensitivity following acute injections of morphine (i.e., "acute dependence"), measured as elevations in intracranial self-stimulation (ICSS) thresholds (anhedonia-like behavior) during naloxone-precipitated and spontaneous withdrawal. Rats were then tested for addiction-like behavior using various measures of i.v. morphine self-administration (MSA) including acquisition, demand, extinction, and reinstatement induced by morphine, stress, and/or drug-associated cues. RESULTS: Greater naloxone-precipitated withdrawal across repeated morphine injections and greater peak spontaneous withdrawal severity following a single morphine injection were associated with lower addiction-like behavior on multiple MSA measures. Withdrawal-induced anhedonia predicted a wider range of MSA measures than did any individual measure of MSA itself. CONCLUSIONS: Our data establish WIA as one of the first behavioral measures to predict individual differences in opioid SA in rodents. This model promises to be useful for furthering our understanding of behavioral and neurobiological mechanisms underlying vulnerability to opioid addiction.
RATIONALE: Understanding factors contributing to individual differences in vulnerability to opioid addiction is essential for developing more effective preventions and treatments, yet few reliable behavioral predictors of subsequent opioid self-administration have been identified in rodents. Sensitivity to the acute effects of initial drug exposure predicts later addiction vulnerability in both humans and animals, but the relationship between sensitivity to withdrawal from initial drug exposure and later drug use vulnerability is unclear. OBJECTIVE: The goal of the current study was to evaluate whether the degree of anhedonia experienced during withdrawal from early opioid exposure predicts subsequent vulnerability to opioid self-administration. METHODS:Rats were first tested for withdrawal sensitivity following acute injections of morphine (i.e., "acute dependence"), measured as elevations in intracranial self-stimulation (ICSS) thresholds (anhedonia-like behavior) during naloxone-precipitated and spontaneous withdrawal. Rats were then tested for addiction-like behavior using various measures of i.v. morphine self-administration (MSA) including acquisition, demand, extinction, and reinstatement induced by morphine, stress, and/or drug-associated cues. RESULTS: Greater naloxone-precipitated withdrawal across repeated morphine injections and greater peak spontaneous withdrawal severity following a single morphine injection were associated with lower addiction-like behavior on multiple MSA measures. Withdrawal-induced anhedonia predicted a wider range of MSA measures than did any individual measure of MSA itself. CONCLUSIONS: Our data establish WIA as one of the first behavioral measures to predict individual differences in opioid SA in rodents. This model promises to be useful for furthering our understanding of behavioral and neurobiological mechanisms underlying vulnerability to opioid addiction.
Authors: Yayi Swain; Peter Muelken; Mark G LeSage; Jonathan C Gewirtz; Andrew C Harris Journal: Pharmacol Biochem Behav Date: 2018-02-02 Impact factor: 3.533
Authors: Joseph R DiFranza; Judith A Savageau; Kenneth Fletcher; Judith K Ockene; Nancy A Rigotti; Ann D McNeill; Mardia Coleman; Constance Wood Journal: Addict Behav Date: 2004-02 Impact factor: 3.913
Authors: Leontien Diergaarde; Tommy Pattij; Ingmar Poortvliet; François Hogenboom; Wendy de Vries; Anton N M Schoffelmeer; Taco J De Vries Journal: Biol Psychiatry Date: 2007-09-19 Impact factor: 13.382
Authors: Andrew C Harris; Peter Muelken; Aleksandra Alcheva; Irina Stepanov; Mark G LeSage Journal: Front Neurosci Date: 2022-05-25 Impact factor: 5.152
Authors: Shirelle X Liu; Mari S Gades; Yayi Swain; Aarthi Ramakrishnan; Andrew C Harris; Phu V Tran; Jonathan C Gewirtz Journal: Drug Alcohol Depend Date: 2021-02-13 Impact factor: 4.492